AllergyTalk Disparities in PIDD Miniseries Episode 2: Addressing the Barriers to Diagnosis of PIDD in Minority/Underserved Populations

image

Price: FREE for members and non-members

This episode will outline each barrier discussed in PIDD miniseries episode 1 and then offer resources and solutions.

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support
This podcast is supported by Pfizer.

Target Audience

Allergists and Immunologists

Learning Objectives

Identify the barriers to health care and diagnosis on PIDD in minority populations

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines an “ineligible company” as companies whose primary business is producing, marketing, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include:

•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers

The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All relevant financial relationships have been mitigated.

Course summary
Available credit: 
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
Course opens: 
01/14/2022
Course expires: 
01/13/2025
Rating: 
0

All identified conflicts of interest have been resolved.

Carla Davis, MD
Chief of Immunology, Allergy, and Retrovirology Section of the department of Pediatrics, Baylor College of Medicine at Texas Children's Hospital and the Janie and Sandra Queen Endowed Chair in Immunology and HIV/AIDS
Dr. Davis has been involved in the identification of health disparities in the field of allergy/immunology as formed research in primary immunodeficiencies in the past 20 years. 

Vivian Hernandez - Trujillo, MD
Director of the Division of Allergy and Immunology and Fellowship training program director for Allergy and Immunology, Nicklaus Children’s Hospital, Miami, FL
Dr Hernandez-Trujillo has been involved in Hispanic outreach for over 20 years. Her basic laboratory experience involved studies of B cell immunodeficiency and agammaglobulinemia.  She has partnered with both the Immune Deficiency Foundation and the ACAAI, as well as media, to increase awareness of PIDD through programs in Spanish for HCPs and patients on PIDDs and, most recently, on COVID. Her current interests include healthcare disparities in Allergy and Immunology disease. 

Gerald Lee, MD is an allergist/immunologist at Children’s Healthcare of Atlanta. Dr. Lee received his medical degree from Case Western Reserve University in 2003. He completed a combined internal medicine/pediatrics residency at Saint Vincent’s Catholic Medical Centers in New York, NY where he was also a pediatric chief resident. He completed his fellowship in allergy/immunology at Cincinnati Children’s Hospital Medical Center in 2011. He is currently an associate professor of pediatrics and internal medicine at the Emory University School of Medicine where he is director of the medical school’s immunology thread and director of the allergy/immunology fellowship. He is an assistant editor for Allergy Watch and co-hosts the ACAAI AllergyTalk podcast. 

 

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
Please login or create an account to take this course.